Magda Marquet
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 15 years
- Director since
- 2023
15 years of board service in total across 5 boards, counting each seat separately. Longest: AnaptysBio Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
TransCode Therapeutics Inc. July 20, 202696.2%
-
Immix Biopharma Inc. May 22, 202699.6%
-
TransCode Therapeutics Inc. August 29, 202587.4%
-
Immix Biopharma Inc. June 20, 202599.5%
-
TransCode Therapeutics Inc. June 13, 202480.8%
-
Immix Biopharma Inc. June 11, 202495.3%
-
AnaptysBio Inc. June 15, 202396.2%
-
Immix Biopharma Inc. June 7, 202398.3%
-
TransCode Therapeutics Inc. May 10, 202392.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | First Tracks Biotherapeutics Inc. | Option exercise | +6,030 | — | — |
| May 22, 2026 | Immix Biopharma Inc. | Grant or award | +6,250 | — | — |
| Jan 15, 2026 | AnaptysBio Inc. | Option exercise | +11,000 | $26.11 | $287,210 |
| Jan 15, 2026 | AnaptysBio Inc. | Open-market sale | −9,290 | $48.12 | $447,035 |
| Jan 15, 2026 | AnaptysBio Inc. | Open-market sale | −1,710 | $48.85 | $83,534 |
| Jun 15, 2025 | AnaptysBio Inc. | Option exercise | +6,030 | — | — |
| Jun 15, 2024 | AnaptysBio Inc. | Option exercise | +3,900 | — | — |
| Jun 14, 2024 | Arcturus Therapeutics Holdings Inc. | Option exercise | +3,131 | — | — |
| May 20, 2024 | Immix Biopharma Inc. | Grant or award | +21,155 | — | — |
| May 15, 2024 | Immix Biopharma Inc. | Grant or award | +25,002 | — | — |
| Sep 6, 2023 | Immix Biopharma Inc. | Open-market purchase | +9,000 | $2.47 | $22,230 |
| Sep 5, 2023 | Immix Biopharma Inc. | Open-market purchase | +10,000 | $2.47 | $24,700 |
| Aug 31, 2023 | Immix Biopharma Inc. | Open-market purchase | +1,000 | $2.01 | $2,010 |
Questions about Magda Marquet
What boards is Magda Marquet on?
Magda Marquet sits on the boards of AnaptysBio Inc., Arcturus Therapeutics Holdings Inc., First Tracks Biotherapeutics Inc., Immix Biopharma Inc. and TransCode Therapeutics Inc.
How long has Magda Marquet served on boards?
Our records show at least 15 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.